文献速递乳房整形与再造

术前阿片类药物使用与乳房再造术后并发症的相关性

Association of preoperative opioid use and postoperative complications following breast reconstruction.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2023-05-13

本研究基于前瞻性登记数据库,纳入354例乳房再造患者,其中29例(8.2%)术前使用阿片类药物。术前阿片类药物使用与首次再造术后60天内并发症风险升高相关(OR 6.28,95%CI 1.69-23.4,p=0.006),也与最终分期再造术后60天内并发症风险升高相关(OR 8.38,95%CI 1.17-59.4,p=0.03);术前使用阿片类药物的患者RAND36躯体与心理评分下降,但未达统计学显著。

要点

  • 术前使用阿片类药物与首次再造术后60天内并发症风险升高相关(OR 6.28,95%CI 1.69-23.4,p=0.006)。
  • 术前使用阿片类药物与最终分期再造术后60天内并发症风险升高相关(OR 8.38,95%CI 1.17-59.4,p=0.03)。
  • 术前使用阿片类药物的患者RAND36躯体与心理评分下降,但未达统计学显著。

核心结论

  • 术前阿片类药物使用与乳房再造患者术后并发症风险升高相关,并可能促成术后生活质量有临床意义的下降。

研究设计与样本

  • 本研究为前瞻性登记数据库回顾性分析,纳入354例接受乳房再造的患者,其中29例(8.2%)术前有阿片类药物使用记录。

主要发现

  • 术前阿片类药物使用与首次再造术后60天内并发症风险升高相关(OR 6.28,95%CI 1.69-23.4,p=0.006)。
  • 术前阿片类药物使用与最终分期再造术后60天内并发症风险升高相关(OR 8.38,95%CI 1.17-59.4,p=0.03)。
  • 术前阿片类药物使用者的RAND36躯体与心理评分下降,但未达统计学显著。
  • 阿片类药物使用在种族、BMI、合并症、既往乳房手术或侧别方面无差异。

临床怎么用

  • 作者认为术前阿片类药物使用与乳房再造术后并发症风险升高相关,并可能促成术后生活质量有临床意义的下降。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Previous studies in orthopedics and general surgery have linked negative patient outcomes with preoperative opioid use. In this study, we investigated the association of preoperative opioid use on breast reconstruction outcomes and quality of life (QoL). METHODS: We reviewed our prospective registry of patients who underwent breast reconstruction for documented preoperative opioid use. Postoperative complications were recorded at 60 days after the first reconstructive surgery and 60 days after the final staged reconstruction. We used a logistic regression model to assess the association between opioid use and postoperative complications, controlling for smoking, age, laterality, BMI, comorbidities, radiation, and previous breast surgery; linear regression to analyze RAND36 scores to evaluate the impact of preoperative opioid use on postoperative QoL, controlling for the same factors; and Pearson chi-squared test to assess factors that may be associated with opioid use. RESULTS: Of the 354 patients eligible for inclusion, 29 (8.2%) were prescribed preoperative opioids. There were no differences in opioid use by race, BMI, comorbidities, previous breast surgery, or laterality. Preoperative opioids were associated with increased odds of postoperative complications within 60 days after the first reconstructive surgery (OR: 6.28; 95% CI: 1.69-23.4; p = 0.006) and within 60 days after the final staged reconstruction (OR: 8.38; 95% CI: 1.17-59.4; p = 0.03). Among patients using opioids preoperatively, the RAND36 physical and mental scores decreased but were not statistically significant. CONCLUSION: We found that preoperative opioid use is associated with increased odds of postoperative complications among patients who underwent breast reconstruction and may contribute to clinically significant declines in postoperative QoL.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Cheah MA, Sarmiento S, Lesko RP, et al. Association of preoperative opioid use and postoperative complications following breast reconstruction. J Plast Reconstr Aesthet Surg. 2023. PMID: 37285777. doi:10.1016/j.bjps.2023.05.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。